IRVING, Texas, Jan. 21, 2011 (GLOBE NEWSWIRE) -- Caris Life Sciences, Inc., a leading biosciences company focused on enabling precise and personalized healthcare through the highest-quality anatomic pathology, molecular profiling, and blood-based diagnostic services, today announced that two distinguished Caris researchers, Dr. David Spetzler and Dr. Traci Pawlowski, presented key findings regarding the Company's circulating microvesicles (cMV) technology at the International Workshop in Exosomes 2011, currently being held in Paris. Application of this technology, called the Carisome™ platform, could facilitate revolutionary developments in blood-based diagnostics, prognostics and therapeutic guidance to aid clinicians and their patients with treatment decisions.
